Amy Comander, Director of Lifestyle Medicine at Mass General Brigham Cancer Institute, shared on LinkedIn:
“I am proud to share that I am now board certified in Obesity Medicine by the American Board of Obesity Medicine.
As a breast oncologist and lifestyle medicine physician, I care for many patients who struggle with weight while also managing treatment side effects and the challenges of survivorship.
Many breast cancer survivors gain weight during and after treatment, often alongside the menopause transition. Too often they are made to feel it is their fault. It is not.
Weight and metabolic health are closely linked to cancer risk, including postmenopausal breast cancer. Our patients deserve care that is evidence-based, free of judgment, and meets them where they are.
That is why I pursued board certification in obesity medicine. I wanted a deeper understanding of how excess adiposity drives cancer risk, through pathways such as chronic inflammation, insulin resistance, and altered hormone signaling, and of how GLP-1 receptor agonists act on central appetite and metabolic regulation.
I believe these therapies will become essential to oncology care. Just as important, I wanted to master the full toolkit for weight management:
- the six pillars of lifestyle medicine (nutrition, physical activity, restorative sleep, stress management, social connection, and avoidance of risky substances),
- behavioral support,
- the other evidence-based strategies that help patients succeed.
I am excited to bring obesity medicine together with lifestyle medicine and menopause care in oncology, so I can offer my patients more complete, whole-person support through treatment and beyond.
Thanks to my patients, and to these colleagues who inspired me to pursue this!”
Other articles from Amy Comander on OncoDaily.
